Literature DB >> 26842912

Immune regulation of canine tumour and macrophage PD-L1 expression.

G Hartley1, E Faulhaber1, A Caldwell1, J Coy1, J Kurihara1, A Guth1, D Regan1, S Dow1.   

Abstract

Expression of programmed cell death receptor ligand 1 (PD-L1) on tumor cells has been associated with immune escape in human and murine cancers, but little is known regarding the immune regulation of PD-L1 expression by tumor cells and tumor-infiltrating macrophages in dogs. Therefore, 14 canine tumor cell lines, as well as primary cultures of canine monocytes and macrophages, were evaluated for constitutive PD-L1 expression and for responsiveness to immune stimuli. We found that PD-L1 was expressed constitutively on all canine tumor cell lines evaluated, although the levels of basal expression were very variable. Significant upregulation of PD-L1 expression by all tumor cell lines was observed following IFN-γ exposure and by exposure to a TLR3 ligand. Canine monocytes and monocyte-derived macrophages did not express PD-L1 constitutively, but did significantly upregulate expression following treatment with IFN-γ. These findings suggest that most canine tumors express PD-L1 constitutively and that both innate and adaptive immune stimuli can further upregulate PD-L1 expression. Therefore the upregulation of PD-L1 expression by tumor cells and by tumor-infiltrating macrophages in response to cytokines such as IFN-γ may represent an important mechanism of tumor-mediated T-cell suppression in dogs as well as in humans.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer; checkpoint molecule; dog; immune

Mesh:

Substances:

Year:  2016        PMID: 26842912     DOI: 10.1111/vco.12197

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  20 in total

1.  Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory Cytokine Release by Mesenchymal Stem Cells Occurs Through Multiple Distinct Biochemical Pathways.

Authors:  William H Wheat; Lyndah Chow; Jade N Kurihara; Daniel P Regan; Jonathan W Coy; Tracy L Webb; Steven W Dow
Journal:  Stem Cells Dev       Date:  2016-12-22       Impact factor: 3.272

2.  Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma.

Authors:  Jennifer A Lenz; Charles-Antoine Assenmacher; Victoria Costa; Katie Louka; Suzanne Rau; Nicholas S Keuler; Paul J Zhang; Robert G Maki; Amy C Durham; Enrico Radaelli; Matthew J Atherton
Journal:  Cancer Immunol Immunother       Date:  2021-08-20       Impact factor: 6.968

Review 3.  Immune exhaustion during chronic infections in cattle.

Authors:  Satoru Konnai; Shiro Murata; Kazuhiko Ohashi
Journal:  J Vet Med Sci       Date:  2016-10-08       Impact factor: 1.267

4.  A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma.

Authors:  Naoya Maekawa; Satoru Konnai; Satoshi Takagi; Yumiko Kagawa; Tomohiro Okagawa; Asami Nishimori; Ryoyo Ikebuchi; Yusuke Izumi; Tatsuya Deguchi; Chie Nakajima; Yukinari Kato; Keiichi Yamamoto; Hidetoshi Uemura; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

Review 5.  Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.

Authors:  Christopher M Fulkerson; Deepika Dhawan; Timothy L Ratliff; Noah M Hahn; Deborah W Knapp
Journal:  Int J Genomics       Date:  2017-04-09       Impact factor: 2.326

6.  Development of canine PD-1/PD-L1 specific monoclonal antibodies and amplification of canine T cell function.

Authors:  Jin Wook Choi; Sita S Withers; Hong Chang; Justin A Spanier; Victoria L De La Trinidad; Harmanpreet Panesar; Brian T Fife; Roger Sciammas; Ellen E Sparger; Peter F Moore; Michael S Kent; Robert B Rebhun; Stephen J McSorley
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

Review 7.  Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans.

Authors:  Deborah W Knapp; Deepika Dhawan; José A Ramos-Vara; Timothy L Ratliff; Gregory M Cresswell; Sagar Utturkar; Breann C Sommer; Christopher M Fulkerson; Noah M Hahn
Journal:  Front Oncol       Date:  2020-01-21       Impact factor: 6.244

Review 8.  Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas.

Authors:  Belen Hernandez; Hibret A Adissu; Bih-Rong Wei; Helen T Michael; Glenn Merlino; R Mark Simpson
Journal:  Int J Mol Sci       Date:  2018-01-30       Impact factor: 5.923

9.  Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease.

Authors:  Andrew S Flies; Nicholas B Blackburn; Alan Bruce Lyons; John D Hayball; Gregory M Woods
Journal:  Front Immunol       Date:  2017-05-03       Impact factor: 7.561

10.  The Expression of Selected Factors Related to T Lymphocyte Activity in Canine Mammary Tumors.

Authors:  Joanna K Bujak; Iwona M Szopa; Rafał Pingwara; Olga Kruczyk; Natalia Krzemińska; Joanna Mucha; Kinga Majchrzak-Kuligowska
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.